Ingvar Karlsson

Overview

Ingvar Karlsson is a Swedish angel investor and board member with extensive experience in finance and corporate governance. He holds a Master of Science in Economics from Lund University and has held various CFO positions and board assignments since 2014. He is currently a part-time CFO at Idogen AB and Elicera AB, both listed on the First North Growth Market. Prior to these roles, he was CFO at Lekolar Group and Doro AB, and has experience with Gambro Group and Perstorp AB in Sweden, France, and Italy. He is also a member of the board at Oxcia AB, a company specializing in biotechnology and healthcare investments. Ingvar Karlsson focuses on early-stage investments in sectors such as biotechnology, healthcare, pharmaceuticals, medical devices, technology, software, renewable energy, environmental services, consumer goods, retail, e-commerce, financial services, education, media, and telecommunications. His investment strategy involves providing capital and strategic guidance to innovative companies with high growth potential. He is known for his hands-on approach and commitment to supporting entrepreneurs in scaling their businesses. His portfolio includes companies like Idogen AB, Elicera AB, and Oxcia AB, reflecting his dedication to advancing healthcare and technology solutions. Ingvar Karlsson's investment philosophy emphasizes long-term value creation, active involvement in portfolio companies, and a focus on sustainable and impactful innovations. He seeks to partner with visionary entrepreneurs who are committed to making a positive difference in their industries and society. His extensive experience in corporate finance and governance enables him to offer valuable insights and support to the companies he invests in, fostering their growth and success in competitive markets.

Investment Focus

• Innovative business models
• Scalable operations
• Experienced management teams
• Clear path to profitability
• Commitment to sustainability and social impact

Portfolio Companies